You are here

  • Home
  • Archive
  • Volume 29, Issue 3
  • Chimeric antigen receptor T-cell (CART) therapy in non-Hodgkin’s lymphoma: the survival gain improves as more mature follow-up data become available

Article metrics

Article menu
Download PDFPDF
PostScript
Letter
Chimeric antigen receptor T-cell (CART) therapy in non-Hodgkin’s lymphoma: the survival gain improves as more mature follow-up data become available

 

Online download statistics by month:

Online download statistics by month: November 2020 to November 2024

AbstractFullPdf
Nov 20206822
Dec 202067565
Jan 202114000
Feb 202113300
Mar 202110211
Apr 202117921
May 20214000
Jun 2021100
Jul 2021400
Aug 2021310
Oct 20217810
Nov 202119511
Dec 202167620
Jan 202219210
Feb 2022111612
Mar 202252010
Apr 2022108932
May 202263512
Jun 202243793
Jul 202210641
Aug 202211200
Sep 202217120
Oct 20222106262
Nov 202253650
Dec 2022102233
Jan 20236040
Feb 20239900
Mar 202313421
Apr 202314510
May 20234211
Jun 20234322
Jul 202312200
Aug 20232000
Sep 20231401
Oct 20232300
Nov 20234111
Dec 20233600
Jan 20241534
Feb 20242000
Mar 20242211
Apr 20243512
May 20243500
Jun 20242600
Jul 202410242
Aug 20245120
Sep 20245700
Oct 20242700
Nov 20242110
Total1060611540